Novotech Global Report: Robust Phase 1 Trial Growth Across Asia Pacific Feb 10, 2023 19:00 HKT/SGT Read More
ONERHT Foundation together with Chui Huay Lim Club and Ee Hoe Hean Club raise close to S$500,000 to promote medical care and support for disadvantaged groups Feb 10, 2023 12:00 HKT/SGT Read More
Ocumension Therapeutics Announces The Completion Of The Phase I Clinical Trial Of Its Class I New Drug For The Treatment Of Dry Eye -- OT-202 Feb 03, 2023 10:01 HKT/SGT Read More
Ocumension Therapeutics Announces Its Patient Enrollment Completed In The Phase III Clinical Trail Of OT-101 In China Feb 01, 2023 10:00 HKT/SGT Read More
Ocumension Therapeutics Appoints Mr. Tim RUAN and Mr. WANG Chong as Chief Financial Officer and Head of Investor Relations respectively Jan 30, 2023 11:38 HKT/SGT Read More
Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating Jan 26, 2023 12:16 HKT/SGT Read More
